IL-15 drug page Clinical trials

Trials with IL-15

Every colorectal cancer trial that includes this drug. Those looking for patients come first.

1Trials
1Recruiting
1Countries
83Planned patients

Showing 1–1 of 1

EBNK-001 Allogeneic NK Cells With Low-Dose IL-15 ± Pembrolizumab in Advanced Solid Tumors
Recruiting Phase 1 83 patients NCT07410676

This Phase 1/2 study evaluates the safety, tolerability, and preliminary anti-tumor activity of EBNK-001 (allogeneic NK cells) given after lymphodepleting cyclophosphamide/fludarabine (CY/FLU) and supported with low-dose IL-15, administere…

China Feb 2026 – Dec 2029 Interventional
Combined with: EBNK-001Pembrolizumab

Where the recruiting trials are